BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22841412)

  • 1. Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity.
    Torun S; Tunc BD; Suvak B; Yildiz H; Tas A; Sayilir A; Ozderin YO; Beyazit Y; Kayacetin E
    Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):491-7. PubMed ID: 22841412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between the neutrophil-lymphocyte ratio and disease activity in patients with ulcerative colitis.
    Demir AK; Demirtas A; Kaya SU; Tastan I; Butun I; Sagcan M; Sahin S; Tasliyurt T; Yilmaz A
    Kaohsiung J Med Sci; 2015 Nov; 31(11):585-90. PubMed ID: 26678939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn's disease severity.
    Gao SQ; Huang LD; Dai RJ; Chen DD; Hu WJ; Shan YF
    Int J Clin Exp Pathol; 2015; 8(11):14779-85. PubMed ID: 26823804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis.
    Masoodi I; Kochhar R; Dutta U; Vaishnavi C; Prasad KK; Vaiphei K; Kaur S; Singh K
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1768-74. PubMed ID: 20136960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of neutrophil-lymphocyte ratio in Alzheimer's disease.
    Kuyumcu ME; Yesil Y; Oztürk ZA; Kizilarslanoğlu C; Etgül S; Halil M; Ulger Z; Cankurtaran M; Arıoğul S
    Dement Geriatr Cogn Disord; 2012; 34(2):69-74. PubMed ID: 22922667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume.
    Yüksel O; Helvaci K; Başar O; Köklü S; Caner S; Helvaci N; Abayli E; Altiparmak E
    Platelets; 2009 Jun; 20(4):277-81. PubMed ID: 19459134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis.
    Celikbilek M; Dogan S; Ozbakır O; Zararsız G; Kücük H; Gürsoy S; Yurci A; Güven K; Yücesoy M
    J Clin Lab Anal; 2013 Jan; 27(1):72-6. PubMed ID: 23292894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the correlations among disease activity index and salivary transforming growth factor-beta 1 and nitric oxide in ulcerative colitis patients.
    Rezaie A; Khalaj S; Shabihkhani M; Nikfar S; Zamani MJ; Mohammadirad A; Daryani NE; Abdollahi M
    Ann N Y Acad Sci; 2007 Jan; 1095():305-14. PubMed ID: 17404043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of serum biomarkers with clinical severity and mucosal inflammation in Chinese ulcerative colitis patients.
    Lok KH; Ng CH; Hung HG; Li KF; Li KK; Szeto ML
    J Dig Dis; 2008 Nov; 9(4):219-24. PubMed ID: 18959594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study.
    Pamuk GE; Vural O; Turgut B; Demir M; Umit H; Tezel A
    Am J Hematol; 2006 Oct; 81(10):753-9. PubMed ID: 16941615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis?
    Posul E; Yilmaz B; Aktas G; Kurt M
    Wien Klin Wochenschr; 2015 Apr; 127(7-8):262-5. PubMed ID: 25576331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-to-Lymphocyte Ratio for Predicting Loss of Response to Infliximab in Ulcerative Colitis.
    Nishida Y; Hosomi S; Yamagami H; Yukawa T; Otani K; Nagami Y; Tanaka F; Taira K; Kamata N; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Tominaga K; Fujiwara Y
    PLoS One; 2017; 12(1):e0169845. PubMed ID: 28076386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosis.
    Cho S; Cho H; Nam A; Kim HY; Choi YS; Park KH; Cho DJ; Lee BS
    Fertil Steril; 2008 Dec; 90(6):2073-9. PubMed ID: 18555226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can neutrophil-lymphocyte ratio be independent risk factor for predicting acute kidney injury in patients with severe sepsis?
    Yilmaz H; Cakmak M; Inan O; Darcin T; Akcay A
    Ren Fail; 2015 Mar; 37(2):225-9. PubMed ID: 25394529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis.
    Osada T; Ohkusa T; Okayasu I; Yoshida T; Hirai S; Beppu K; Shibuya T; Sakamoto N; Kobayashi O; Nagahara A; Terai T; Watanabe S
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S262-7. PubMed ID: 19120909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum concentrations and surface expression on peripheral white blood cells of decay-accelerating factor (CD55) in patients with active ulcerative colitis.
    Makidono C; Mizuno M; Nasu J; Hiraoka S; Okada H; Yamamoto K; Fujita T; Shiratori Y
    J Lab Clin Med; 2004 Mar; 143(3):152-8. PubMed ID: 15007304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential markers for ulcerative colitis: a retrospective study.
    Feng W; Liu Y; Zhu L; Xu L; Shen H
    BMC Gastroenterol; 2022 Nov; 22(1):485. PubMed ID: 36424535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated markers of thrombin generation and fibrinolysis in patients with active and quiescent ulcerative colitis.
    Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Vassiliadis T; Mpoumponaris A; Giouleme O; Evgenidis N
    Med Sci Monit; 2009 Nov; 15(11):CR563-72. PubMed ID: 19865055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease.
    Czub E; Herzig KH; Szaflarska-Popawska A; Kiehne K; Socha P; Woś H; Kamińska B; Błaszczyński M; Cichy W; Bała G; Brodzicki J; Grzybowska-Chlebowczyk U; Walkowiak J
    Scand J Gastroenterol; 2007 Oct; 42(10):1147-50. PubMed ID: 17852864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.